Best Ophthalmology Journals (2026): Ranked by Impact and Accessibility
A ranked guide to the top 12 ophthalmology journals by impact factor, acceptance rate, APC, and review time, covering clinical, surgical, and basic science venues.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Ophthalmology publishing has a clear hierarchy that hasn't changed much in years, but the options below the top tier have expanded significantly. The field covers surgical outcomes, retinal disease, glaucoma management, corneal biology, neuro-ophthalmology, pediatric eye disease, and vision science. Each of these areas has dedicated journals, and the generalist ophthalmology titles compete intensely for the biggest clinical trials and translational discoveries.
What makes ophthalmology publishing distinct is the strong divide between clinical and basic science outlets. Journals like Ophthalmology and JAMA Ophthalmology want clinical evidence. Investigative Ophthalmology & Visual Science (IOVS) and Experimental Eye Research want bench science. Sending the wrong type of paper to the wrong journal is one of the fastest paths to a desk rejection.
Quick Answer: Top 5 Ophthalmology Journals
- Progress in Retinal and Eye Research (IF ~14.7) for commissioned reviews
- Ophthalmology (IF ~9.5) for clinical research (AAO flagship)
- JAMA Ophthalmology (IF ~9.0) for evidence-based clinical work
- American Journal of Ophthalmology (IF ~5.5) for clinical and surgical research
- IOVS (IF ~4.8) for basic and translational vision science
Full Comparison Table
Journal | IF | Acceptance Rate | APC | Review Time | Scope |
|---|---|---|---|---|---|
Progress in Retinal and Eye Research | ~14.7 | <5% | Subscription | Invited only | Reviews |
Ophthalmology | ~9.5 | ~8% | $3,800 (OA option) | 4-8 weeks | Clinical, all subspecialties |
JAMA Ophthalmology | ~9.0 | ~8% | Subscription | 4-8 weeks | Clinical, evidence-based |
British Journal of Ophthalmology | ~4.6 | ~15% | $3,500 (OA option) | 6-10 weeks | Clinical, international |
American Journal of Ophthalmology | ~5.5 | ~18% | $3,400 (OA option) | 6-10 weeks | Clinical and surgical |
IOVS | ~4.8 | ~25% | $2,200 (OA option) | 6-10 weeks | Basic and translational |
Retina | ~4.2 | ~20% | Subscription | 6-10 weeks | Retinal diseases |
Ocular Surface | ~6.1 | ~18% | $3,300 (OA option) | 4-8 weeks | Cornea and ocular surface |
Ophthalmology Science | ~3.5 | ~30% | $3,000 (OA) | 4-6 weeks | Open access, AAO |
TVST | ~2.8 | ~35% | $1,800 (OA) | 4-8 weeks | Translational vision science |
Experimental Eye Research | ~3.4 | ~30% | $3,200 (OA option) | 6-10 weeks | Basic eye science |
BMJ Open Ophthalmology | ~2.3 | ~35% | $2,100 (OA) | 4-8 weeks | Broad, open access |
Elite Tier: The Highest-Impact Ophthalmology Journals
Progress in Retinal and Eye Research
This journal has the highest IF in ophthalmology, but it's essentially invitation-only for thorough review articles. You don't submit original research here. If you're an established expert and receive an invitation, it's a significant career milestone. The articles are exhaustive, often 30+ pages, and become definitive references in their areas.
Ophthalmology
The American Academy of Ophthalmology's flagship journal is the most competitive venue for original clinical research in the field. It publishes large RCTs, major epidemiological studies, and high-impact clinical findings across all subspecialties. The editorial process is fast and professional. If your study has the potential to change clinical practice in any area of ophthalmology, this is where it should go first. The journal also publishes excellent editorials and research letters.
JAMA Ophthalmology
Part of the JAMA network, this journal benefits from the brand's massive reach into general medicine. It prioritizes evidence-based clinical research, systematic reviews, and health services research. Publications here get noticed by non-ophthalmologists, which matters for work with public health implications. The review process is rigorous and expects impeccable methodology.
Strong Tier: Competitive and Respected
American Journal of Ophthalmology (AJO)
AJO is one of the oldest continuously published ophthalmology journals and remains a strong choice for clinical and surgical research. It's less selective than Ophthalmology or JAMA Ophthalmology but still competitive. AJO is particularly good for surgical outcome studies, case series with large numbers, and clinical innovations. The readership is primarily practicing ophthalmologists.
British Journal of Ophthalmology (BJO)
BJO serves as the primary international clinical ophthalmology journal outside the US market. It publishes clinical research, reviews, and educational content with a global perspective. European and Asian authors sometimes find a warmer reception here compared to the US-centric journals. The quality of review is consistent, and the journal has a loyal readership.
Retina
If your work is specifically about retinal diseases, Retina is the leading subspecialty journal. It publishes clinical research, surgical techniques, and imaging studies related to retinal conditions. The focused readership means your work reaches the exact specialists who need to see it. Sending retina-specific research to a generalist journal often means less expert review.
Ocular Surface
For cornea, tear film, dry eye, and ocular surface disease research, this journal has become the definitive venue. Its IF has climbed steadily as dry eye research has expanded. If your work involves the anterior segment or ocular surface biology, consider Ocular Surface before generalist titles.
IOVS
Investigative Ophthalmology & Visual Science is ARVO's flagship and the top journal for basic and translational vision research. It doesn't publish clinical trials. Instead, it's the home for laboratory science, animal models, imaging technology development, and visual neuroscience. If your paper involves wet lab work or computational modeling related to vision, IOVS is the appropriate target.
Accessible Tier: Open Access and Emerging Options
Ophthalmology Science
AAO launched this OA companion to the main Ophthalmology journal, and it's quickly become a credible option. It publishes original research that's scientifically sound but may not reach the novelty bar for the parent journal. The connection to AAO provides visibility, and the OA model ensures broad access.
TVST (Translational Vision Science & Technology)
ARVO's OA journal bridges bench science and clinical application. It's particularly good for imaging studies, technology development, and translational work. The APC is lower than most competitors, making it accessible for researchers with limited funding. The review process is constructive.
Experimental Eye Research
For basic science that doesn't reach IOVS, Experimental Eye Research is a natural alternative. It publishes cell biology, molecular biology, and pharmacology studies related to the eye. The journal has a long history and stable readership in the basic science community.
BMJ Open Ophthalmology
A broad OA journal that accepts well-designed studies across all of ophthalmology. The acceptance rate is higher and the bar is scientific soundness rather than perceived impact. A pragmatic option for observational studies, small trials, and research from resource-limited settings.
Decision Framework: Where Does Your Paper Fit?
If your paper is a large RCT with practice-changing results, Ophthalmology should be your first submission. JAMA Ophthalmology is a close second.
If your paper is clinical but subspecialty-specific, consider Retina or Ocular Surface before generalist journals. Expert reviewers at subspecialty journals will evaluate your work more fairly.
If your paper is basic science or translational, IOVS is the standard. For work that doesn't reach IOVS, try Experimental Eye Research or TVST.
If your paper needs open access, Ophthalmology Science and TVST are the best society-backed options. BMJ Open Ophthalmology offers a broader scope.
If your paper is a surgical outcome study or technique description, AJO has the strongest tradition of publishing surgical research.
Common Mistakes in Ophthalmology Journal Selection
Sending basic science to Ophthalmology. The AAO flagship is a clinical journal. It publishes original clinical research, not laboratory science. Send bench work to IOVS or Experimental Eye Research.
Ignoring subspecialty journals. Retina, Ocular Surface, Journal of Glaucoma, and Cornea all serve specific communities. Your retinal imaging study will get better reviewers and more engaged readers at Retina than at a generalist journal.
Overlooking JAMA Ophthalmology's general medicine reach. If your ophthalmology research has public health or primary care implications (screening, prevention, health economics), JAMA Ophthalmology's cross-specialty readership amplifies impact.
Submitting without a visual abstract. Many ophthalmology journals now expect graphical abstracts. Check requirements before submitting.
Misunderstanding IOVS's scope. IOVS is broad within basic and translational science, but it doesn't publish clinical trials or case series. Know the boundary.
Prepare Your Manuscript for Success
Ophthalmology journals have specific expectations for image quality, statistical reporting, and structured abstracts. Before submitting, use Manusights' AI review to check your paper against common rejection triggers. Catching issues early saves you review cycles and helps you land at the right journal on the first or second attempt.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.